Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Inovio
Inovio
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
You need to be a subscriber to read this article.
Click here
to find out more.
Pharmaceutical
Zika outbreak gives rise to global fears
Zika may not be a new virus but its newly confirmed ability to cause foetal brain abnormalities makes the search for a treatment or a vaccine a high priority. Dr Sarah Houlton looks at the latest initiatives
Drug Delivery
Inovio to buy needle-free injection technology from Bioject Medical Technologies for US$5.5m
Non-invasive integrated injection and electroporation device could enhance mass immunisation against infectious diseases
Research & Development
AstraZeneca signs third cancer deal in seven days
MedImmune enters into cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
Research & Development
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania join forces to tackle influenza and antibiotic-resistant bacteria
The project is awarded US$12.2m by US Defense Advanced Research Projects Agency (DARPA)
Research & Development
Inovio Pharmaceuticals continues building senior team with appointment of VP of Quality
Also makes three promotions in Legal, Clinical and Investor Relations
Drug Delivery
Inovio and US army receive US$3.5m grant
To continue development of a mass vaccination device using electroporation technology
Research & Development
PATH Malaria Vaccine Initiative and Inovio to accelerate malaria vaccine development
Follow-on agreement will lead to clinical trials
Subscribe now